UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549


                                    FORM 8-K
                                 CURRENT REPORT
      PURSUANT TO SECTION 13 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

-------------------------------------------------  -----------------------------
Date of Report (Date of earliest event reported)            March 2, 2005
-------------------------------------------------  -----------------------------


                                    NUTRACEA
--------------------------------------------------------------------------------
              Exact name of registrant as specified in its charter)


            California               0-32565                   87-0673375
--------------------------------------------------------------------------------
  (State or other jurisdiction     (Commission               (IRS Employer
        of incorporation)          File Number)           Identification No.)


              1261 Hawks' Flight Court, El Dorado Hills, CA  95762
--------------------------------------------------------------------------------
                     (Address of principal executive office

Registration's telephone number, including area code:     (916) 933-7000
                                                     ---------------------------


--------------------------------------------------------------------------------
          (Former name or former address, if changed since last report)


Check  the  appropriate  box  below  if  the  Form  8-K  filing  is  intended to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

[_]  Written communications pursuant to Rule 425 under the Securities Act (17
     CFR 230.425)

[_]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
     240.14a-12)

[_]  Pre-commencement communications pursuant to Rule 14d-2(b) under the
     Exchange Act (17 CFR 240.14d-2(b))

[_]  Pre-commencement communications pursuant to Rule 13e-4(c) under the
     Exchange Act (17 CFR 240.13e-4(c)).



SECTION 5  -  CORPORATE GOVERANCE AND MANAGEMENT

ITEM 5.02   APPOINTMENT OF DIRECTOR.

On  March  2, 2005, NutraCea announced the appointment of David S. Bensol, R.Ph.
to  the  Board  of Directors.  Mr. Bensol has over 30 years of experience in the
medical  services  and  pharmaceutical  industries and is a licensed pharmacist.
Mr.  Bensol's  most  recent  position  was  as CEO of Critical Homecare, Inc., a
company  which  he  founded  in  2002,  which provides home medical supplies and
healthcare  services.

SECTION 9  -  FINANCIAL STATEMENT AND EXHIBITS

ITEM 9.01     FINANCIAL STATEMENTS AND EXHIBITS.

              (c)     Exhibits
                      --------

                      99.1    Press Release dated Mach 2, 2005


                                   SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

Dated:  March 7, 2005                         NUTRACEA
                                        -----------------------------
                                                   (Registrant)


                                              /s/ Bradley D. Edson
                                        ------------------------------------
                                        Bradley D. Edson, President